Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.66 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.66 |
| ▸ | MAPT | P10636 | 4/20 | 0.66 |
| ▸ | BLM | P54132 | 4/20 | 0.66 |
| ▸ | LMNA | P02545 | 3/20 | 0.66 |
| ▸ | PMP22 | Q01453 | 3/20 | 0.66 |
| ▸ | MEN1 | O00255 | 3/20 | 0.66 |
| ▸ | TSHR | P16473 | 2/20 | 0.66 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.66 |
| ▸ | MPO | P05164 | 1/20 | 0.66 |
| ▸ | PTPRA | P18433 | 1/20 | 0.65 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.62 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.61 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.61 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.61 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.61 |
| ▸ | HTR1A | P08908 | 1/20 | 0.61 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30381776 | 1.00 | KMT2A (0.66) | KMT2AKDM4EMAPTBLMLMNA | |
| SCHEMBL274625 | 1.00 | KMT2A (0.66) | KMT2AKDM4EMAPTBLMLMNA | |
| SCHEMBL29855626 | 1.00 | KMT2A (0.66) | KMT2AKDM4EMAPTBLMLMNA | |
| SCHEMBL8502601 | 1.00 | KMT2A (0.66) | KMT2AKDM4EMAPTBLMLMNA | |
| Tryptophan SCHEMBL17165924 | 0.89 | KMT2A (0.71) | KMT2AKDM4EMAPTBLMLMNA | |
| SCHEMBL19871231 | 0.89 | KMT2A (0.73) | KMT2AKDM4EMAPTBLMLMNA | |
| SCHEMBL30405928 | 0.89 | KMT2A (0.73) | KMT2AKDM4EMAPTBLMLMNA | |
| SCHEMBL29382361 | 0.89 | KMT2A (0.73) | KMT2AKDM4EMAPTBLMLMNA | |
| SCHEMBL454983 | 0.89 | KMT2A (0.73) | KMT2AKDM4EMAPTBLMLMNA | |
| SCHEMBL307776 | 0.89 | KMT2A (0.73) | KMT2AKDM4EMAPTBLMLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 749 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260022515-A2 | PROCESS FOR DYEING TEXTILES | SANKO TEKSTIL ISLETMELERI SAN VE TIC AS (TR) | 2026-01-22 | — | — | US | claimed |
| EP-4110328-B1 | INTERVENTION STRATEGY FOR PREVENTION OR TREATMENT OF DIABETES MELLITUS, AUTOIMMUNE DISEASE, INFLAMMATORY DISEASE OR CARDIOVASCULAR DISEASE | Stichting Amsterdam UMC (NL) | 2026-01-07 | — | — | EP | claimed |
| CN-119517408-A | Method for establishing death prediction model of new-onset type 2 diabetes and application | 中南大学湘雅二医院 | 2025-02-25 | — | — | CN | claimed |
| US-20240368831-A1 | PROCESS FOR DYEING TEXTILES | SANKO TEKSTIL ISLETMELERI SAN. VE TIC. A.S. | 2024-11-07 | — | — | US | claimed |
| WO-2024130198-A9 | NOVEL TRYPTOPHANASES FROM STREPTOMYCES WITH NOVEL PROPERTIES AND THE USES THEREOF | CONAGEN INC. (US) | 2024-08-22 | — | — | WO | claimed |
| WO-2024130198-A2 | NOVEL TRYPTOPHANASES FROM STREPTOMYCES WITH NOVEL PROPERTIES AND THE USES THEREOF | CONAGEN INC. (US) | 2024-06-20 | — | — | WO | claimed |
| CN-118207197-A | Immobilization of thermophilic archaea tryptophan synthase on magnetic bead-T4 phage capsid composite carrier | 江苏海洋大学 | 2024-06-18 | — | — | CN | claimed |
| CN-114222841-B | Textile dyeing process | 尚科纺织企业工业及贸易公司 | 2024-04-12 | — | — | CN | claimed |
| CN-117625504-A | Engineering bacterium combined into 6,6' -dibromo indigo as well as preparation method and application thereof | 南京合谷生命生物科技有限公司 | 2024-03-01 | — | — | CN | claimed |
| CN-116836959-A | Enzyme composition for synthesizing neomycin derivative and application thereof | 山东大学 | 2023-10-03 | — | — | CN | claimed |
| US-20030170222-A1 | Beta-superfamily conotoxins | UNIVERSITY OF UTAH RESEARCH FOUNDATION | 2003-09-11 | — | — | US | claimed |
| US-20020173449-A1 | O-superfamily conotoxin peptides | UTAH RESEARCH FOUNDATION, UNIVERSITY OF | 2002-11-21 | — | — | US | claimed |
| EP-1246635-A1 | O-SUPERFAMILY CONOTOXIN PEPTIDES | University of Utah Research Foundation (US) | 2002-10-09 | — | — | EP | claimed |
| WO-2002060923-A2 | B-SUPERFAMILY CONOTOXINS | COGNETIX, INC. (US) | 2002-08-08 | — | — | WO | claimed |
| EP-1219603-A2 | Tryptophan analogs in proteins, peptides and peptidic structures | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2002-07-03 | — | — | EP | claimed |
| WO-2001049312-A2 | O-SUPERFAMILY CONOTOXIN PEPTIDES | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2001-07-12 | — | — | WO | claimed |
| EP-1039923-A1 | GAMMA-CONOPEPTIDES | University of Utah Research Foundation (US) | 2000-10-04 | — | — | EP | claimed |
| WO-1999030732-A1 | GAMMA-CONOPEPTIDES | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 1999-06-24 | — | — | WO | claimed |
| US-5889147-A | OLIGOPEPTIDE, POLYPEPTIDE FROM VENOM OF A CONE SNAIL | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 1999-03-30 | — | — | US | claimed |
| WO-1998031705-A1 | BROMO-TRYPTOPHAN CONOPEPTIDES | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 1998-07-23 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260022515-A2 | PROCESS FOR DYEING TEXTILES | TDO2, TPH2, IDO2 | KMT2A 693/4885KDM4E 522/4885MAPT 2931/4885 |
| US-20030170222-A1 | Beta-superfamily conotoxins | KCNN4, KCNA2, KCNA1 | KMT2A 4088/4885KDM4E 4354/4885MAPT 3647/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.